The clinical impact of increased sensitivity PT and APTT coagulation assays

American Journal of Clinical Pathology

Volumn 112, Issue 2, 1999, Pages 225-232

  Wojtkowski, Thea A ^a   Rutledge, Joe C ^a   Matthews, Dana C ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Activated partial thromboplastin time; aPTT; Cardiac surgery; Coagulation; Pediatric; Prothrombin time; PT; Screening

Indexed keywords

ADOLESCENT; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; CARDIOVASCULAR SURGERY; CHILD; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SCREENING TEST;

EID: 0033490748     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/112.2.225     Document Type: Article

References (28)

1. Hathaway WE, SH Goodnight Jr. Disorders of Hemostosis and Thrombosis: A Clinical Guide. New York, NY: McGraw Hill; 1993.
2. Lake CL, RA Moore. Blood: Hemostasis, Transfusion, and Alternatives in the Perioperative Period. New York, NY: Raven Press; 1995:8-11, 153-228.
3. Kang J, Bordsky L, Danziger I, et al. Coagulation profile as a predictor for post-tonsillectomy and adenoidectomy (T+A) hemorrhage. Int J Pediatr Otorhinolaryngol. 1994;28:157-165.
4. Bachmann F. Diagnostic approach to mild bleeding disorders. Semin Hematol. 1980;17:292-305.
5. Konkle BA. Laboratory evaluation of von Willebrand disease. Clin Chem. 1995;41:489-490.
6. Werner EJ, Abshire TC, Giroux DS, et al. Relative value of diagnostic studies for von Willebrand disease. J Pediatr. 1992;121:34-38.
7. Bolger WE, Parsons DS, Potempa L. Preoperative hemostatic assessment of the adenotonsillectomy patient. Otolaryngol Head Neck Surg. 1990;103:396-405.
8. Burk CD, Miller L, Handler SD, et al. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics. 1992;89:691-695.
9. Bushik JB, Eisenberg JM, Kinman J, et al. Pursuit of abnormal coagulation screening tests generates modest hidden preoperative costs. J Gen Intern Med. 1989;4:493-497.
10. Close HL, Kryzer TC, Nowlin JH, et al. Hemostatic assessment of patients before tonsillectomy: a prospective study. Otolaryngol Head Neck Surg. 1994;111:733-738.
11. Eisenberg JM, Clarke JR, Sussman SA. Prothrombin and partial thromboplastin times as preoperative screening tests. Arch Surg. 1982;117:48-51.
12. Houry S, Georgeac C, Hay JM, et al. A prospective multicenter evaluation of preoperative hemostatic screening tests. Am Surg. 1995;170:19-23.
13. Kiley V, Stuart JJ, Johnson CA. Coagulation studies in children with isolated recurrent epistaxis. J Pediatr. 1982;100:579-581.
14. Colon-Otero G, Gilchrist GS, Holcomb GR, et al. Preoperative evaluation of hemostasis in patients with congenital heart disease. Mayo Clin Proc. 1987;62:379-385.
15. Rohrer MJ, Michelotti MC, Nahrwold DL. A prospective evaluation of the efficacy of preoperative coagulation testing. Ann Surg. 1988;208:554-557.
16. Schmidt JL, Yaremchuk KL, Mickelson SA. Abnormal coagulation profiles in tonsillectomy and adenoidectomy patients. Henry Ford Hosp Med J. 1990;38:33-35.
17. Suchman AL, Mushlin AI. How well does the activated partial thromboplastin time predict postoperative hemorrhage? JAMA. 1986;256:750-753.
18. Currimbhoy Z. Transitory anticoagulants in healthy children. Am J Pediatr Hematol Oncol. 1984;6:210-212.
19. Harper K, Friedland ML. Hageman factor deficiency presentation and implications for management. Conn Med. 1992;56:469-471.
20. Lammle B, Wuilletin WA, Huber I, et al. Thromboembolism and bleeding tendency in congenital factor XII deficiency: a study on 74 subjects form 14 Swiss families. Thromb Haemost. 1991;65:117-121.
21. Rodeghiero F, Castaman G, Ruggeri M, et al. Fibrinolytic studies in 13 unrelated families with factor XII deficiency. Haematologica. 1991;76:28-32.
22. Edmunds LH. Blood-surface interactions during cardiopulmonary bypass. J Card Surg. 993;8:404-410.
23. Perrin EJ, Ray MJ, Hawson GA. The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery. Blood Coagul Fibrinolysis. 1995;6:650-658.
24. Brodsky I. Coagulation abnormalities in cyanotic heart disease. J Pediatr. 1970;77:918-921.
25. Ekert H, Gilchrist GS, Stanton R, et al. Hemostasis in cyanotic congenital heart disease. J Pediatr. 1970;76:221-230.
26. Green D. Correction of haemostatic defect in cyanotic congenital heart disease. Lancet. 1971;2:486-487.
27. Naiman JL. Clotting and bleeding in cyanotic congenital heart disease. J Pediatr. 1970;76:333-335.
28. Mozes B, Lubin D, Modan B, et al. Evaluation of an intervention aimed at reducing inappropriate use of preoperative blood coagulation tests. Arch Intern Med. 1989;149:1836-1838.